Literature DB >> 12775229

Colorectal cancer screening for the natural population of Beijing with sequential fecal occult blood test: a multicenter study.

Shirong Li1, Zhaohua Nie, Nan Li, Junxiang Li, Ping Zhang, Zhaoxu Yang, Shankun Mu, Yaping Du, Jichun Hu, Shenyuan Yuan, Hanting Qu, Taichang Zhang, Shixin Wang, Enyu Dong, Defang Qi.   

Abstract

OBJECTIVE: To assess the prevalence of colorectal cancer (CRC) in Beijing and the reliability of the sequential fecal occult blood test (SFOBT) for CRC screening.
METHODS: Of the natural population (48 100 persons) in several Beijing communities, we screened 26 827 persons with age over 30 using the SFOBT screening program, Guaiacum Fecal Occult Blood Test (GFOBT), Immuno Fecal Occult Blood Test (IFOBT), and colonoscopies.
RESULTS: The screening rate of the population was 74%. The positive rate of SFOBT was 5.6%. The prevalence of CRC in the entire population of Beijing was therefore calculated to be 36.57/10(5). Of 12 CRC detected patients, 4 cases were in stage Dukes A (33.33%), 7 cases in stage Dukes B (58.33%), only 1 case (8.34%) in stage Dukes C.
CONCLUSIONS: The prevalence of CRC in Beijing is one of the highest in China. Individuals at high risk for CRC or those over 50 years of age should be considered as primary candidates for screening. SFOBT screening is a cost-effective and reliable method for early detection of CRC.

Entities:  

Mesh:

Year:  2003        PMID: 12775229

Source DB:  PubMed          Journal:  Chin Med J (Engl)        ISSN: 0366-6999            Impact factor:   2.628


  11 in total

1.  Implications of CEA and p53 overexpression in the poor prognosis of colorectal cancer.

Authors:  Wesam A Nasif; Mahmoud Lotfy; Ibrahim H El-Sayed; Ayman El-Meghawry El-Kenawy; Mohamed El-Shahat; Nabil Gad El-Hak
Journal:  Med Oncol       Date:  2006       Impact factor: 3.064

2.  Association between CTLA-4 rs231775 polymorphism and risk of colorectal cancer: a meta analysis.

Authors:  Lijie Wang; Fangfang Jing; Dan Su; Tingting Zhang; Bo Yang; Shunchang Jiao; Yi Hu; Li Bai
Journal:  Int J Clin Exp Med       Date:  2015-01-15

3.  Prognostic factors in 165 elderly colorectal cancer patients.

Authors:  Ke-Jun Nan; Hai-Xia Qin; Guang Yang
Journal:  World J Gastroenterol       Date:  2003-10       Impact factor: 5.742

4.  CTLA-4 +49A>G polymorphism is associated with the risk but not with the progression of colorectal cancer in Chinese.

Authors:  Peng Qi; Can-ping Ruan; Hao Wang; Fei-guo Zhou; Xin-yun Xu; Xing Gu; Yun-peng Zhao; Tong-hai Dou; Chun-fang Gao
Journal:  Int J Colorectal Dis       Date:  2009-09-29       Impact factor: 2.571

5.  An integrated approach to the detection of colorectal cancer utilizing proteomics and bioinformatics.

Authors:  Jie-Kai Yu; Yi-Ding Chen; Shu Zheng
Journal:  World J Gastroenterol       Date:  2004-11-01       Impact factor: 5.742

6.  Colorectal Cancer Screening Based on Age and Gender: A Cost-Effectiveness Analysis.

Authors:  Martin C S Wong; Jessica Y L Ching; Victor C W Chan; Thomas Y T Lam; Arthur K C Luk; Sunny H Wong; Siew C Ng; Simon S M Ng; Justin C Y Wu; Francis K L Chan; Joseph J Y Sung
Journal:  Medicine (Baltimore)       Date:  2016-03       Impact factor: 1.889

Review 7.  Strategies for prevention of gastrointestinal cancers in developing countries: a systematic review.

Authors:  Ahmad Zia Shams; Ulrike Haug
Journal:  J Glob Health       Date:  2017-12       Impact factor: 4.413

Review 8.  Flexible sigmoidoscopy versus faecal occult blood testing for colorectal cancer screening in asymptomatic individuals.

Authors:  Øyvind Holme; Michael Bretthauer; Atle Fretheim; Jan Odgaard-Jensen; Geir Hoff
Journal:  Cochrane Database Syst Rev       Date:  2013-10-01

9.  A haplotype variation affecting the mitochondrial transportation of hMYH protein could be a risk factor for colorectal cancer in Chinese.

Authors:  Huimei Chen; Lizhi Xu; Qiufeng Qi; Yanweng Yao; Ming Zhu; Yaping Wang
Journal:  BMC Cancer       Date:  2008-09-23       Impact factor: 4.430

10.  Colorectal cancer screening with fecal occult blood test: A 22-year cohort study.

Authors:  Peng Jin; Zi-Tao Wu; Shi-Rong Li; Shu-Jun Li; Ji-Heng Wang; Zhi-Hong Wang; Jian-Guo Lu; Xin-Juan Cui; Ying Han; Jianyu Rao; Jian-Qiu Sheng
Journal:  Oncol Lett       Date:  2013-06-14       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.